| 000 | 00740 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513060910.0 | ||
| 264 | 0 | _c19941020 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.309.6953.540 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHickey, F M | |
| 245 | 0 | 0 |
_aAdvertisement for Zantac. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _c |
||
| 300 |
_a540 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdvertising |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRanitidine _xtherapeutic use |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 309 _gno. 6953 _gp. 540 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.309.6953.540 _zAvailable from publisher's website |
| 999 |
_c8086249 _d8086249 |
||